Author

Prashant Sinha

University of Delhi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Ashwin JainarayananiD· 2 shared Samir Kumar Brahmachari· 2 shared Anirudh S. Chellappa· 1 shared Ankit Kumar PathakiD· 1 shared Pragya Jaiswal· 1 shared Sanjeev JainiD· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Ashwin JainarayananORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intronic miRNA Mediated Gene Expression Regulation Controls Protein Crowding Inside the Cell

Prashant Sinha, Pragya Jaiswal, Ashwin Jainarayanan, Samir Kumar Brahmachari

The paper analyzes how intronic miRNAs regulate gene expression in specific cellular contexts and shows their role in controlling protein crowding through translation regulation.

Gene · Sep 4, 2018Peer-reviewedBioinformatics

Multi-scale analysis of schizophrenia risk loci: Integrating centenarian genomes and spatio-temporal expression profiles suggest the need for adjunctive therapeutic interventions for neuropsychiatric disorders.

Anirudh S. Chellappa, Ankit Kumar Pathak, Prashant Sinha, Ashwin Jainarayanan, Sanjeev Jain, Samir Kumar Brahmachari

The paper integrates centenarian genomes and spatio-temporal expression profiles to identify potential drug targets for schizophrenia, suggesting repurposed therapies for neuropsychiatric disorders.

bioRxiv · Aug 1, 2018 · PreprintBioinformatics